- Role
- Country
- Date of registration
- Address
EUDAMED last updated this device on Oct 20, 2025
542500512BXOG01YFBE-MF-000001909Primary placement in Belgium; available across 18 countries total.
| Country | On market since | Until |
|---|---|---|
| BelgiumPrimary placement | Oct 3, 2023 | Still on market |
| Czechia | Oct 3, 2023 | Still on market |
| Germany | Oct 3, 2023 | Still on market |
| Denmark | Oct 3, 2023 | Still on market |
| Finland | Oct 3, 2023 | Still on market |
| France | Oct 3, 2023 | Still on market |
| Croatia | Oct 3, 2023 | Still on market |
| Hungary | Oct 3, 2023 | Still on market |
| Ireland | Oct 3, 2023 | Still on market |
| Italy | Oct 3, 2023 | Still on market |
| Luxembourg | Oct 3, 2023 | Still on market |
| Malta | Oct 3, 2023 | Still on market |
| Netherlands | Oct 3, 2023 | Still on market |
| Portugal | Oct 3, 2023 | Still on market |
| Romania | Oct 3, 2023 | Still on market |
| Slovenia | Oct 3, 2024 | Still on market |
| Slovakia | Oct 3, 2023 | Still on market |
| XI | Oct 3, 2023 | Still on market |
V9017ORAL ADMINISTRATION PREPARATIONS NOT INCLUDED IN OTHER CLASSESCertificate health across this manufacturer's portfolio.
BE23/00000293Supplemented